Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$715M
-
Value change
-
+$79.1M
-
Put/Call ratio
-
0.84
-
Number of buys
-
124
-
Number of sells
-
-51
-
Price
-
$16.98
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2015
192 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2015.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
of 56M outstanding shares and own 75.16% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (7.64M shares), BlackRock Fund Advisors (2.48M shares), Murphy Michael R (1.88M shares), Invesco Ltd. (1.47M shares), Ranger Investment Management, L.P. (1.4M shares), Apex Capital Management (1.38M shares), VANGUARD GROUP INC (1.31M shares), Ameriprise Financial Inc (1.26M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.07M shares), and KOPP INVESTMENT ADVISORS LLC (891K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.